Volume 19 - Issue 5 - May, 2007
'Wound Care' Reading Is Fundamental
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 2328 reads
Dear Readers,
“Do you know a good book about wound care that I can read?” “Where can I find information about wound care?” These are questions I am asked on a weekly basis. I am able to give an answer based on the information I have and the books that are available to me. Dr. William Olser once said, “…we have no better means of judging the intelligence of a profession than by its general collection of books. A physician who does not need a library, who does not read one or two of the best weeklies and monthlies, soon sinks to the level of th
Letter to the Editor
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 1835 reads
Dear Editor:
Congratulations to Professor Gardner and colleagues (Gardner S, Frantz R, Hillis SL, Park H, Scherubel M. Diagnostic validity of semiquantitative swab cultures. WOUNDS. 2007;19(2):31–38) for again writing about and promoting an old, perhaps neglected, technique for wound culture—the Levine technique. We were able to confirm the work that Norman Levine did while at Brooke Army Medical Center with work at the Burn Unit at Kansas University Medical Center in the late 1970s.1 Rather than using the tip of the swab and “rot
Letter to the Editor
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 1689 reads
Dear Editor:
We agree with Dr. Zamierowski that our study that compared semiquantitative swab cultures to quantitative tissue and swab cultures would have been strengthened had the order in which the swab specimens were obtained been randomized. In retrospect, we should have discussed this issue as a limitation of the study findings. By not randomizing the order of swab acquisition, bias may have been introduced into the study findings. As suggested by Dr. Zamierowski, this bias may have resulted in fewer microbes being collected by the second swab, the semiquantitati
Section Editor's Message
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 1787 reads
Veterinary Wounds
This paper is the sequel to that published in the May 2005 edition of WOUNDS1 that described the evaluation of an aliamide-containing gel in the treatment of dermatological wounds by utilization of developments in high resolution ultrasonography (HRU) to estimate decreasing volume of the healing wound over time without interfering with the healing process. In both animal and clinical studies the quantification of healing when attempting to evaluate small differences between experimental and control groups, has always been d
Assessment of the Effect of an Aliamide-containing Topical Gel by Evaluation of the Reduction of Wound Volume Measured by High R
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 3694 reads
Disclosure: Funding for this work was provided by the Royal Veterinary College Internal Grant Scheme and by Innovet Italia Srl.
Treatment of skin wounds in pets is a very common activity for practicing veterinary surgeons. Existing therapies for skin wounds take the form of surgical reapposition or grafting to close large skin defects, and the use of barriers and antimicrobial agents that maintain normal wound healing biology rather than accelerating and improving wound healing.1 With improved understanding of wound biology comes the possibility o
Combined Treatment Modalities of Hyperbaric Oxygen Therapy, Bilayer Matrix Wound Dressing, and Negative Pressure Therapy in Pati
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 5039 reads
The temporoparietal fascial flap is a reliable, versatile, and strong flap that may be used pedicled or free to treat a wide variety of difficult problems. Temporoparietal fascia flaps are well vascularized, thin and pliable, and readily accept skin grafts. In 1993, Cheney et al1 described 21 cases using the flap for a variety of reconstructions in the head and neck. An analysis of 123 temporoparietal fascia flaps by Park et al2 in Korea reported a 94% success rate using these flaps for total auricular reconstructions. Temporoparietal flaps can drape into concavities a
Painful Leg Ulcers: A Misdiagnosed Case Report With Literature Review
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 6724 reads
Leg ulcers are a common symptom in patients with vascular disease. Ninety-five percent of chronic leg ulcers are due to ischemia, stasis, neurotrophic conditions, and other conditions, such as vasculitis, hypertension, and syphilis.1 The following case report presents an uncommon cause for a leg ulcer, which was initially suspected to be a vascular disease.
Case Report
A 56-year-old man was admitted to the authors’ department with painful leg ulcers of 3 months duration. Upon examination, 12 ulcerations ranging from 10 mm2 x 10 mm
An Analysis of the Effectiveness of Skin Grafting to Treat Chronic Venous Leg Ulcers
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 4986 reads
The pathology of chronic venous leg ulcers (CVLUs) often presents itself and greatly influences the everyday life of the patient. Nearly 150,000 Lithuanian patients suffer from chronic venous insufficiency of the legs—almost 30,000 of which are attributed to venous leg ulcers.1 The literature states that the frequency of CVLU varies from 0.18% to 1.9% of the entire population.2–4 It should be noted that the frequency of CVLU depends on the age of the patient. In the group of patients who are older than 65 years, CVLU appear in 36 people of 100,000 and accou
Odor Absorbing Hydrocolloid Dressings for Direct Wound Contact
- Thu, 9/4/08 - 11:52am
- 0 Comments
- 6222 reads
Disclosure: Dr. Lipman discloses that he has received monetary compensation to conduct the study, write the manuscript, and lecture for the company producing the products discussed from Avery Dennison Medical. This study was fully funded by Avery Dennison Medical.
Patients in institutional settings, such as hospitals and nursing homes, often have or acquire chronic wounds such as those resulting from venous insufficiency and pressure ulcers—these wounds can possess a very offensive odor.1 The most direct way of avoiding or eliminating wound o
May 2007
- Thu, 9/4/08 - 11:52am
- 1 Comments
- 1982 reads
Derma Sciences Business Agreement Attributes to Patient Lifestyle Needs
Derma Sciences, Inc. (Princeton, NJ) announces that the company has obtained a licensing agreement with C-Boot LTD, a medical biosystems company based in Israel.
The agreement was established for the marketing, sales, and distribution rights of C-Boot’s patented advanced therapeutic devices for the treatment of chronic venous insufficiency (CVI), venous ulcers, lymphedema, deep vein thrombosis (DVT) prevention, and other conditions that require compression therapy.
Derma Sciences
- « Previous
- | Page 1 of 2 |
- Next »
_sm.jpg)
